PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ERECTILE DYSFUNCTION, BASED ON A DRUG, IN A GEL, INHIBITING THE PDE5 ENZYME (PHOSPHODIESTERASE TYPE 5)

The invention relates to a pharmaceutical composition which inhibits the phosphodiesterase enzyme, containing 1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo (4,3 - d) pyrimidine-5-il)-4-etoxyphenyl)sulfonyl)-4-methylpiperazine as an active agent associated with at least one pharmaceutically...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	RAMÓN RODRÍGUEZ HERNÁNDEZ, RAÚL ARTURO MORENO HINOJOSA, OLIVER DANIEL WALLS FLORES, REYNA ASTRID SALTO RIVERA
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to a pharmaceutical composition which inhibits the phosphodiesterase enzyme, containing 1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo (4,3 - d) pyrimidine-5-il)-4-etoxyphenyl)sulfonyl)-4-methylpiperazine as an active agent associated with at least one pharmaceutically acceptable excipient, in the pharmaceutical form in gel packets or in a small dosing device. La presente invención se refiere a una composición farmacéutica, inhibidora de la enzima fosfodiesterasa que contiene 1 - ((3 - (6,7 - dihidro - 1 - metil - 7 - oxo - 3 - propil - 1 H-pirazolo (4,3 - d) pirimidin - 5 - il) - 4 - etoxifenil) sulfonil) - 4- met ilpiperazina, como agente activo asociado con uno o mas excipientes farmacéuticamente aceptables; en la forma farmacéutica en sobres de gel o en un dispositivito dosificador.